SINGAPORE, October 18, 2023. Quadria Capital (“Quadria”), one of Asia’s largest healthcare-focused private equity firms, today announced that it has held a first close for its third healthcare fund at approximately 60% of the target fund size. The fund will continue the firm’s focus on providing growth capital to promising companies to address the need for quality, accessible and equitable healthcare across Asia.
With this first close, Fund III is more than halfway to reaching its target fund size of US$ 800 million. Commitments have come from both existing and new investors including institutional investors, insurance and pension funds, development finance institutions and family offices across the United States, Europe and Asia-Pacific. The fund will continue to invest in large, scalable, market-leading businesses in South and Southeast Asia with the potential to generate attractive financial returns while making a social impact on communities they serve.
Abrar Mir, Co-Founder and Managing Partner of Quadria Capital, said: “We would like to thank all our investors and partners for supporting Quadria’s ambitions of becoming Asia’s leading healthcare investor. The strong first close of our third fund serves as a clear validation of investors’ confidence in our strategy and consistent execution. We are on track to reach our final target for this fund, which puts us in good stead to execute our strategy and capitalise on a rich pipeline of opportunities.”
Dr Amit Varma, Co-Founder and Managing Partner of Quadria Capital, said: “Asia healthcare remains a highly resilient sector with tremendous growth prospects, especially given rising regional demand and huge unmet needs. We have unique expertise and networks to support and accelerate the growth of portfolio companies poised to become industry leaders and drive social impact in the region.”
Quadria recently completed its first deal backed by commitments to Fund III. The firm has agreed to invest up to US $155 million in Maxivision Eye Hospital, one of India’s leading and fastest-growing private eyecare clinics. The first tranche of roughly US$ 75 million gives Quadria a significant minority stake, and a further investment of up to US$ 80 million would give it a controlling interest. This investment and Quadria’s broader support will enhance Maxivision’s ability to expand the scale of its business and serve the growing demand for eye care in underserved South and West Indian cities.
About Quadria Capital
Founded in 2012, Quadria is an Asia healthcare-focused private equity firm with assets under management of over US$ 3.4 billion, maximising returns by investing in the high growth healthcare sector of some of the world’s fastest-growing economies in South Asia and Southeast Asia, including Healthcare Delivery, Life Sciences, Medical Technology and Associated Healthcare Services subsectors. The firm aims to create significant and sustainable shareholder value by supporting strong, professionally run, stable and scalable healthcare organisations to address the critical and undersupplied healthcare needs in Asia.
For more information, please visit https://quadriacapital.com
Investor Relations Contact
Gerald Ng, Head of Investor Relations
Email: [email protected]